Advance faster into the clinical phase
HEMEX CRO helps you plan, manage, conduct, and report your clinical study. Together, we will prove safety and efficacy to obtain market approval.
Flexible & Dedicated
CRAs experienced in Pharmaceuticals (large and small molecules), Medical Devices (MD) and in vitro Diagnostics (IVD), and software as a medical device (SaMD).
Fast Communications
From Preclinical Development through Phase I – Phase IV clinical trials, Real World Evidence (RWE), decentralised clinical trials, PMCF studies, and registry trials.
Maximized Efficiency
To reduce costs; our services are specifically tailored to your needs.
Effective Solutions
Over 150 clinical projects in the following therapeutic areas: infectious diseases, cardiovascular diseases, oncology, women’s health, orthopaedics, urology, and advanced cell therapy.
“The first steps are often the hardest, but our team is here to help you! We are specialized in preparing submission dossiers, ensuring patient safety, and double-checking that your data are collected and analyzed to the highest standards.”
Our Solutions
We offer full-service CRO assistance.
- Protocol Writing
- Feasibility & Screening Site Selection
- Informed Consent Form (ICF) Writing
- Competent Authority (CA) and Ethics Committee (EC) Submission, Follow up & Approval
- Site Monitoring Visits
- Project/Site/Data Management
- Remote Data Monitoring
- Medical Monitoring
- Statistical Analysis Plan & Report
- Serious Adverse Event (SAE) Narrative & Reporting
- Final Clinical Study Report (CSR)
1/6
Get your
trial started.
2/6
Fast site selection
and setup.
3/6
Comply with
current regulations.
4/6
Site monitoring and
management.
5/6
Prove your efficacy and
effectiveness.
6/6
Turn data into a
meaningful narrative.
“HEMEX’s CRO team is multinational, diverse, and has a strong academic and clinical background. Our main goal is to make your clinical trial a success story.”
What customers say about us
HEMEX provides Scailyte a range of services, from administrative to highly specialized regulatory and clinical development support. Working at HEMEX incubator, whenever we have a question, we can immediately address it. We’re happy to continue our journey with such a trusted partner.
Dr. Peter Nestorov
CEO, Scailyte
From the start of Resistell, HEMEX supports our company in the clinical operations and also back us with its investment arm. The understanding of startup needs, makes HEMEX a unique partner in our journey to the market.
Dr. Danuta Cichocka
CEO, Resistell
With its impressive commitment to advance and fund healthcare innovations, its deep understanding of startup needs and its solid expertise in supporting regulatory and clinical operations, HEMEX is an exceptional partner that has been and continues to be instrumental in our journey.
Mathieu Horras
CEO, ASPIVIX
Benefit from a Global Clinical Network
Americas
Argentina
Brazil
Canada
Chile
Colombia
Mexico
Peru
Puerto Rico
USA
Europe & Africa
Austria
Belgium
Bulgaria
Croatia
Czechia
Denmark
Egypt
Estonia
Finland
France
Germany
Hungary
Italy
Latvia
Macedonia
Netherlands
Norway
Poland
Portugal
Republic of the Congo
Romania
Russia*
Spain
South Africa
Sweden
Switzerland
Turkey
UK
Ukraine*
*Halted operations
Related services
Clinical Research Organization
More services:
Regulatory Affairs
More services:
Quality Management
More services: